Avid Radiopharmaceuticals Is A Philadelphia Based Company Focused On Developing Diagnostic Solutions To Enhance Global Healthfounded By Drdaniel Skovronskyavid Operates As A Subsidiary Of Eli Lilly And Companywhich Acquired It In 2010The Company Is Located At The University City Science Center Research Campusbenefiting From Its Proximity To Major Educational Institutions Avid Specializes In Creating Molecular Imaging Agentsparticularly For Neurodegenerative Diseasesone Of Its Key Products Is Florbetapir18F A Radioactive Tracer That Detects Beta Amyloid Plaques In Patients With Memory Issuesmarking The First Fda Approved Method For Identifying This Alzheimer S Disease Pathologyavid Is Also Engaged In Clinical Trials For18F Av 133Aimed At Identifying Dopaminergic Degeneration With An Annual Revenue Of $55 4 Million And A Team Of Around 80 Employeesavid Radiopharmaceuticals Is Committed To Advancing Diagnostic Solutions And Improving Patient Outcomes
